• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Cell and Gene Therapy Innovation Right From The Start

  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Events & Presentations
    • Elevated Insights
  • Careers
  • Contact
  • Search
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Induced Pluripotent Stem Cells (iPSCS)
    • RNA, Cell, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Publications
    • Elevated Insights
  • Careers
  • Contact
  • End-to-End Capabilities


    End-to-End Capabilities Overview

    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Enabling Services
  • Technology Platforms


    Technology Platform Overview

    • Gene Editing
    • Induced Pluripotent Stem Cells (iPSCS)
    • RNA, Cell, Protein & Vector Engineering
  • Therapeutic Design & Approaches


    Therapeutic Design & Approaches Overview

    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
Home / Team Members / Melissa Carpenter, PHD

Melissa Carpenter, PHD

Chief Scientific Officer of Regenerative Medicine

Follow On LinkedIn

About Melissa

For over 25 years, Melissa has worked on the development of cell therapies using human adult and pluripotent stem cells in academia and industry. Her work involves discovery research and the translation of this research into therapeutic products, including developing strategies for cell manufacturing, preclinical development, and paving the regulatory path for the development of stem cell therapies. Melissa serves as a member of the Board of Directors of TreeFrog Therapeutics (developing iPS-derived cell therapies) and the International Society for Stem Cell Research (ISSCR). In addition, she serves on the scientific advisory committee of the Novo Nordisk Foundation Center for Stem Cell Medicine (ReNew).

Prior to ElevateBio, Melissa founded Carpenter Group Consulting, which works with early-stage companies, academic groups, and investors to translate discovery-based research into stem cell therapies suitable for clinical entry. In her consulting role, Melissa has provided strategic, scientific, manufacturing, preclinical, and regulatory guidance for the development of over 75 cell and gene therapies. Melissa has a track record of launching programs and forming and building teams focused on early-stage stem cell therapies.

‍

Education and Accomplishments

Melissa has been named inventor on 34 issued US patents and has over 50 peer-reviewed publications in the stem cell field. She received her PhD from the Laboratory of Cellular and Molecular Neurobiology at University of California, Irvine, and received her B.Sc. in Psychology from the University of Oregon.

Back to team

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2023 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • End-to-End Capabilities
  • Technology Platforms
  • Therapeutic Design & Approaches
  • Partnering
  • About
  • Investors & Media
  • Careers
  • Contact